CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Large Growth in Short Interest

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 36,700 shares, a growth of 184.5% from the February 13th total of 12,900 shares. Based on an average daily trading volume, of 117,300 shares, the days-to-cover ratio is presently 0.3 days.

CERo Therapeutics Price Performance

CERo Therapeutics stock traded up $0.00 during midday trading on Friday, hitting $0.01. 6,740 shares of the company’s stock were exchanged, compared to its average volume of 106,276. CERo Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.13. The stock has a 50-day moving average price of $0.01 and a two-hundred day moving average price of $0.01.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.